Exhibit 10.5
AGREEMENT
THIS AGREEMENT (the "Agreement"), effective as of January 1, 2002 by and
between E-Z-EM, Inc., a Delaware corporation (the "Company") and Xxxxxx Xxxxx
("Xxxxx").
WHEREAS, Xxxxx is the Chairman of the Board of Directors of the Company
(the "Board") and previously served as President and Chief Executive Officer of
the Company; and
WHEREAS, the Company recognizes Xxxxx'x past contributions to the Company
and wants to provide for the continuation of his contributions to the Company.
NOW, THEREFORE, the parties hereto, intending to be legally bound hereby,
agree as follows:
1. Position. Xxxxx shall provide to the Company those services set forth on
Exhibit A hereto, as Exhibit A may be amended from time to time with the
consent of both the Company and Xxxxx (the "Services"). Xxxxx shall
provide up to a maximum of 125 days per annum to Company, as may be
necessary to perform the Services. In the event such period of time is
exceeded, and per the specific request of the Chief Executive Officer of
the Company (the "CEO") and on reasonable notice, Xxxxx agrees to provide
additional services and to perform projects and assignments assigned by
the CEO for additional compensation to be agreed upon in advance between
Xxxxx and the CEO and approved by the Board.
2. Independent Contractor. Xxxxx shall perform the Services as an independent
contractor and not as an employee of the Company. The Company shall not
withhold any amounts for taxes from payments made to Xxxxx. Xxxxx shall be
responsible for the payment of all taxes in connection with amounts paid
to him by the Company and shall indemnify the Company and hold the Company
harmless with respect to the payment of all such taxes.
3. Board of Directors. The Company agrees to propose and nominate Xxxxx as a
Director of the Company for a three year term on the Company's slate of
Directors when Xxxxx comes up for re-election in October 2002. The Company
acknowledges that it is the current intention of the Board that Xxxxx be
elected as the Chairman of the Board for a one-year term commencing
October 2002, or for such longer term as the Board determines. So long as
Xxxxx is the Chairman of the Company he shall receive twice the Director's
fees and other compensation (including cash, stock and options) as is
received by other Directors of the Company. Payment of director fees and
other compensation shall commence on December 1, 2001. If at any time
Xxxxx is a Director (but not the Chairman) of the Company he shall receive
the normal Director's fees and compensation paid to other Directors.
4. Term. The term of this Agreement shall be thirty-six (36) months,
commencing on January 1, 2002 and terminating on December 31, 2004 (the
"Term"); provided that the Term shall sooner terminate upon the earlier of
Xxxxx'x death or a Change in Control. For purposes of this Agreement, a
"Change in Control" shall have the meaning set forth in the Company's
standard Change in Control Agreement.
-79-
5. Compensation. In consideration of his performance of the Services, and in
addition to the compensation and benefits to which Xxxxx is entitled under
paragraphs 3, 6, 7, 8, 9 and 10 hereof, Xxxxx shall receive thirty-six
(36) equal monthly payments of $20,833.34 payable on the first day of each
month commencing January 1, 2002 (it being understood that the payments
due on January 1, 2002 and February 1, 2002 shall be paid upon the
execution and delivery of this Agreement by Xxxxx and the Company). Xxxxx
shall continue to receive such payments upon his disability (as defined in
the Company's standard employment policy), but such payments shall cease
upon the end of the month in which the sooner to occur of Xxxxx'x death or
a Change in Control occurs.
6. Bonus. Xxxxx shall be entitled to receive a pro-rata portion of the bonus
payable pursuant to the existing Company and AngioDynamics Bonus Plans, if
any such bonus is paid, for the period June, 1, 2001 to November 30, 2001.
Commencing December 1, 2001, Xxxxx shall no longer participate in either
the Imaging or AngioDynamics Bonus Plans. Notwithstanding the foregoing,
nothing shall restrict the Board (or the AngioDynamics board) from
awarding Xxxxx, in its discretion, a bonus or additional compensation for
services rendered or goals achieved above and beyond the duties and
responsibilities assigned to Xxxxx under this Agreement.
7. Benefits. During the Term, the Company shall pay for or reimburse Xxxxx
for medical and dental benefits (of equal coverage to the existing
Company policies for Xxxxx) for Xxxxx and his spouse.
8. Business Expenses. During the Term and only so long as Xxxxx is Chairman
of the Board, the Company shall provide Xxxxx with an annual sum of up to
$80,000 to reimburse Xxxxx for reasonable business expenses incurred in
connection with his performance of the Services. All meetings and travel
shall be pre-approved by the CEO based upon an annual meeting and travel
schedule established by Xxxxx and the CEO. If Xxxxx'x business expenses
exceed $80,000 per annum, he shall be reimbursed for such additional
expenses only if they are pre-approved by the CEO and the Board, whose
approval shall not be unreasonably withheld if such business expenses are
reasonable and necessary.
9. Vehicle, Office and Secretary. During the Term, the Company shall furnish
Xxxxx with an automobile for his use in accordance with Company policy
(either the vehicle currently being used by Xxxxx or an equivalent new
vehicle) and his current office and secretary.
10. Split Dollar Insurance. The Company shall continue to honor its
obligations under the split-dollar life insurance agreements for Xxxxx
dated May 27, 1998 (the "Split Dollar Agreements").
11. Confidentiality. Xxxxx shall execute the Company's standard Nondisclosure
and Assignment of Inventions Agreement (the "NDA"), which shall prohibit
his use and disclosure of confidential information during the Term and
thereafter until such information no longer constitutes confidential
information.
12. Non-Competition. Provided that the Company shall not be in material breach
of its obligations under paragraphs 1, 3, 5, 6, 7, 8, 9 and 10 hereof (it
being understood that no such material breach shall be deemed to have
occurred until and unless Xxxxx has provided the Company with written
notice of such material breach and the Company has not cured such breach
in all material respects within thirty days after receipt of such notice),
Xxxxx agrees that during the Term and for a period of twelve (12) months
following the termination or expiration of this Agreement, he shall
-80-
not in any state or territory of the United States in which the Company
conducts business, directly or indirectly, own, manage, operate, control,
be employed by, be a shareholder of, be an officer of, participate in,
contract with or be connected in any capacity or any manner with any
business that directly or indirectly (whether through related companies or
otherwise) manufactures, develops, designs, distributes, sells, or markets
any product, device or equipment substantially similar to any product,
device or equipment which during the Term has been manufactured, marketed,
sold or distributed by the Company or any product, device or equipment
(unless such product, device or equipment has been abandoned by the
Company or such product, device or equipment is not competitive with the
Company's business) which the Company was developing or designing during
the Term for future manufacturing, marketing, sale and distribution;
provided, however that nothing herein shall prohibit Xxxxx from owning,
directly or indirectly, as a passive investor, in the aggregate not more
than one percent (1%) of the outstanding publicly traded stock of any
company that competes with the Company.
13. Miscellaneous.
13.1. Notices. All notices, requests and other communications hereunder
must be in writing and shall be deemed to have been duly given only
if delivered personally against written receipt or by facsimile
transmission or mailed by prepaid first class certified mail, return
receipt requested, or mailed by overnight courier prepaid, to the
parties at the following addresses or facsimile numbers:
If to the Company:
E-Z-EM, Inc.
000 Xxxx Xxxxxx
Xxxxxxxx, XX 00000
Attn: President & CEO
Facsimile: (000) 000-0000
If to Xxxxx:
Xxxxxx X. Xxxxx
00 X.X. Xxxxxxx Xxxx
Xxx Xxxxxxxx, XX 00000
Facsimile: (000) 000-0000
With a copy to:
Xxxx X. Xxxxx, Esq.
Xxxxxxxxx Xxxxxxxx Xxxxx & Xxxxx LLP
000 Xxxx Xxxxxx
Xxx Xxxx, XX 00000-0000
Facsimile: (000) 000-0000
Any party may from time to time change its address or facsimile
number for the purpose of notices to that party by a similar notice
specifying a new address or facsimile number, but no such change
shall be deemed to have been given until it is actually received by
the party sought to be charged with its contents.
13.2. Entire Agreement. This Agreement, together with the NDA and the
Split Dollar Agreement, supersede all prior discussions and
agreements between the parties with respect to the subject matter
hereof and thereof and contain the sole and entire agreement
-81-
between the parties hereto with respect to the subject matter hereof
and thereof. Without limiting the foregoing, all prior agreements
between the Company and Xxxxx relating to his employment by the
Company, his provision of services to the Company and the payment to
him of compensation (salary, bonus and otherwise) and benefits
(stock, options, insurance and otherwise) are hereby agreed to be
null and void; provided, however, the foregoing shall not apply to
options, vested or unvested, previously granted to Xxxxx by the
Company or AngioDynamics.
13.3. Waiver. Any term or condition of this Agreement may be waived at any
time by the party that is entitled to the benefit thereof, but no
such waiver shall be effective unless set forth in a written
instrument duly executed by or on behalf of the party waiving such
term or condition. No waiver by any party of any term or condition
of this Agreement, in any one or more instances, shall be deemed to
be or construed as a waiver of the same or any other term or
condition of this Agreement on any future occasion. All remedies,
either under this Agreement or by law or otherwise afforded, shall
be cumulative and not alternative.
13.4. Amendment. This Agreement may be amended, supplemented or modified
only by a written instrument duly executed by or on behalf of each
party hereto.
13.5. No Third Party Beneficiary. The terms and provisions of this
Agreement are intended solely for the benefit of each party hereto
and their respective successors or permitted assigns, and it is not
the intention of the parties to confer third-party beneficiary
rights, and this Agreement does not confer any such rights, upon any
other person.
13.6. Assignment; Binding Effect. Neither this Agreement nor any right,
interest or obligation hereunder of Xxxxx may be assigned (by
operation of law or otherwise) without the prior written consent of
the Company and any attempt to do so shall be void.
13.7. Invalid Provisions. If any provision of this Agreement is held to be
illegal, invalid or unenforceable under any present or future law,
and if the rights or obligations of any party hereto under this
Agreement shall not be materially and adversely affected thereby,
(a) such provision shall be fully severable, (b) this Agreement
shall be construed and enforced as if such illegal, invalid or
unenforceable provision had never comprised a part hereof, (c) the
remaining provisions of this Agreement shall remain in full force
and effect and shall not be affected by the illegal, invalid or
unenforceable provision or by its severance herefrom and (d) in lieu
of such illegal, invalid or unenforceable provision, there shall be
added automatically as a part of this Agreement a legal, valid and
enforceable provision as similar in terms to such illegal, invalid
or unenforceable provision as may be possible.
13.8. Governing Law. This Agreement shall be governed by and construed in
accordance with the domestic laws of the State of New York, without
giving effect to any choice of law or conflict of law provision or
rule (whether of the State of New York or any other jurisdiction)
that would cause the application of the laws of any jurisdiction
other than the State of New York.
-82-
13.9. Dispute Resolution. Any dispute, controversy or claim between the
Company and the Consultant arising from or in connection with this
Agreement (a "Dispute") regardless of the magnitude thereof or the
amount in controversy or whether such Dispute would otherwise be
considered justiciable or ripe for resolution by a court or arbitral
tribunal, shall be submitted to, and finally determined by,
arbitration in accordance with the AAA Commercial Rules. Any award
pursuant to such arbitration may be enforced in any court having
competent jurisdiction. The prevailing party shall recover its legal
fees and costs from the non-prevailing party.
13.10. Construction. The parties hereto agree that this Agreement is the
product of negotiation between sophisticated parties and
individuals, all of whom were represented by counsel, and each of
whom had an opportunity to participate in and did participate in,
the drafting of each provision hereof. Accordingly, ambiguities in
this Agreement, if any, shall not be construed strictly or in favor
of or against any party hereto but rather shall be given a fair and
reasonable construction without regard to the rule of contra
proferentum.
13.11. Counterparts. This Agreement may be executed in any number of
counterparts, each of which shall be deemed an original, but all of
which together shall constitute one and the same instrument.
13.12. Captions. Captions herein are inserted for reference purposes only
and shall not affect the interpretation or construction of this
Agreement.
13.13. Further Assurances. Each party hereto, at its own expense, shall
deliver all such further instruments and documents as may reasonably
be requested by the other party in order to fully carry out the
intent and accomplish the purposes of the transactions referred to
therein.
IN WITNESS WHEREOF, the Parties have executed and delivered this Agreement as of
the date first above written.
E-Z-EM, Inc.
By: /s/ Xxxxxxx Xxxxxxxx By: /s/ Xxxxxx Xxxxx
--------------------------- --------------------------------
Name: Xxxxxxx Xxxxxxxx Xxxxxx Xxxxx
Its: CEO
-83-
EXHIBIT A
CHAIRMAN DUTIES:
1. Chair regular and special BOD Meetings, with the assurance that they are
held in a timely fashion. Will Chair both the AngioDynamics and the E-Z-EM
Boards.
2. Consult with the President/CEO of E-Z-EM and AngioDynamics, as well as
with other BOD members, to set the agenda for the BOD Meetings.
3. COB is to ensure that the BOD focuses on governance and shareholder rights
with attention paid to maximizing shareholder value.
4. COB to provide advice and leadership to the BOD; communications to the BOD
will be made on a regular and timely fashion.
5. Provide advice and support to the President and CEO.
6. COB will work with the investment community, where appropriate, to support
the efforts of the various Investor Relation Programs of the entire
Company. He will assist the President/CEO as appropriate. He will use his
networking connections, as well as those of the other members of the BOD,
to assist in this effort.
7. COB, based on his industry experience and knowledge, will provide support
and guidance to the various strategic and tactical initiatives of the
Company.
8. Meet on a regular basis with the President/CEO to discuss the Company and
its strategy.
SERVICES:
A. Attend selective industry meetings to keep abreast of current trends. A
defined set of meetings will be established and reviewed on an annual
basis. Typical of these meetings will be: RSNA, SGR, SCIVR, DDW, and ACG.
(This list is not meant to be all-inclusive).
B. The COB will support the Management Team in specific negotiations as
requested by the President/CEO or directed by the BOD.
C. The COB may be asked to establish industry panels in specific areas that
will support the Company's strategic plan.
D. The COB will use his extensive industry network to search out,
investigate, and recommend projects that have the potential to be
"killer-projects" and thus be change agents or paradigm shifters to
enhance the growth of the Company and thus enhance shareholder value. (I
call this the "RFD" projects.)
The above will be accomplished within the established budgets, and procedures,
of the Company.
-84-
